News

Pharmabiz1h

SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis

SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...
The Pharma Letter1h

FDA review timeline extended for NUZ-001 IND clinical hold

Australia’s Neurizon Therapeutics saw its shares rise 10% to A$0.16 today. after it revealed that it has been informed by the ...

Mark Kirton, ex-Maple Leaf and fighter for ALS treatment, dies at 67

Former Leafs posted the news Sunday evening. Kirton, 67, was diagnosed with amyotrophic lateral sclerosis, or Lou Gehrig’s ...

Groundbreaking brain chip decodes people’s inner monologues in real time

A new brain-computer interface technology can decode a user’s inner monologue, an advance that scientists say can help ...

Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market

Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based ...
CanucksDaily11h

Former Vancouver Canucks Forward Tragically Passes Away at the Age of 67

A former Vancouver Canucks forward, who also spent time with the Toronto Maple Leafs and Detroit Red Wings, has sadly passed ...